(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

If you have diabetes, dehydration can make it harder to control your blood sugar. Learn why and how to avoid it.

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with ...

Type 2 diabetes is a disease that impacts millions of Americans. Dr. Dequina Nicholas said she’s seen the affect of diabetes ...

Researchers at Lund University in Sweden have carried out the most detailed mapping to date of the epigenome in the cells ...

The PIONEER TEENS trial compared oral semaglutide at maximum tolerated doses with placebo in adolescents aged 10 to 17 years with T2D.

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose ...

Children and adolescents with type 2 diabetes had an improvement in HbA1c at 26 weeks with a once-daily oral GLP-1, according ...

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

Oral semaglutide lowered HbA1c vs placebo in a phase 3 trial in adolescents with type 2 diabetes, pending full data and ...

In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates.